CVR number 36560878
Industry 463800

Bodylab ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.1% 1.9% 1.6% 1.5% 1.1%  
Credit score (0-100)  84 69 74 75 84  
Credit rating  A A A A A  
Credit limit (kDKK)  2,904.1 12.7 131.3 485.6 5,060.9  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  35,781 54,473 51,558 70,156 76,581  
EBITDA  11,996 23,569 22,966 37,763 43,472  
EBIT  9,005 21,508 21,196 35,950 41,680  
Pre-tax profit (PTP)  8,238.0 23,223.0 20,697.0 37,043.0 41,176.3  
Net earnings  6,210.6 17,909.0 15,914.0 28,891.0 32,111.3  
Pre-tax profit without non-rec. items  8,238 29,677 20,697 37,043 41,176  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  2,907 4,090 7,567 7,867 9,202  
Shareholders equity total  52,310 31,719 47,633 76,525 108,637  
Interest-bearing liabilities  76.4 638 69.0 0.0 7,854  
Balance sheet total (assets)  83,097 70,744 92,509 118,681 164,516  
Net Debt  -25,772 -7,235 -9,400 -4,165 47.6  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  35,781 54,473 51,558 70,156 76,581  
Gross profit growth  20.2% 52.2% -5.4% 36.1% 9.2%  
Employees  0 48 49 55 56  
Employee growth %  0.0% 0.0% 2.1% 12.2% 1.8%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  83,097 70,744 92,509 118,681 164,516  
Balance sheet change%  29.9% -14.9% 30.8% 28.3% 38.6%  
Added value  11,996.5 23,569.0 22,966.0 37,720.0 43,471.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -5,883 -1,806 779 -1,513 -457  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  25.2% 39.5% 41.1% 51.2% 54.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  19.7% 44.7% 27.9% 37.0% 34.5%  
ROI %  28.8% 78.6% 55.3% 62.4% 50.3%  
ROE %  12.6% 42.6% 40.1% 46.5% 34.7%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  63.0% 44.8% 51.5% 64.5% 66.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -214.8% -30.7% -40.9% -11.0% 0.1%  
Gearing %  0.1% 2.0% 0.1% 0.0% 7.2%  
Net interest  0 0 0 0 0  
Financing costs %  6,942.8% 1,326.7% 576.0% 5,979.7% 196.7%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.2 0.5 0.6 1.5 1.8  
Current Ratio  2.1 1.7 2.0 2.8 2.9  
Cash and cash equivalent  25,847.9 7,873.0 9,469.0 4,165.0 7,806.4  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  33,547.8 27,710.0 41,807.0 70,925.0 101,792.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 491 469 686 776  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 491 469 687 776  
EBIT / employee  0 448 433 654 744  
Net earnings / employee  0 373 325 525 573